4//SEC Filing
Feider Stephen 4
Accession 0002048588-25-000004
CIK 0001674632other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:15 PM ET
Size
10.8 KB
Accession
0002048588-25-000004
Insider Transaction Report
Form 4
Feider Stephen
Chief Financial Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2025-10-03−4,982→ 69,695 totalExercise: $5.10Exp: 2033-09-13→ Common Stock (4,982 underlying) - Sale
Common Stock
2025-10-03$22.28/sh−1,154$25,709→ 44,041 total - Sale
Common Stock
2025-10-03$21.52/sh−3,828$82,368→ 45,195 total - Exercise/Conversion
Common Stock
2025-10-03$5.10/sh+4,982$25,408→ 49,023 total
Footnotes (4)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
- [F2]The weighted average sale price for the transaction reported was $21.5172 and the range of prices were between $21.04 and $22.0144. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $22.2778 and the range of prices were between $22.0438 and $22..47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Documents
Issuer
Beta Bionics, Inc.
CIK 0001674632
Entity typeother
Related Parties
1- filerCIK 0002048588
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:15 PM ET
- Size
- 10.8 KB